Basic Studies on Biochemical and Molecular Biological Diagnosis of Tumor Hypoxia by PET
Basic Studies on Biochemical and Molecular Biological Diagnosis of Tumor Hypoxia by PET
批准号:
17591260
负责人:
FURUKAWA Takako
金额:
$2.37万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2007
中文摘要
肿瘤缺氧的无创成像对预测治疗结果和制定治疗计划有很大帮助。Cu-二乙酰-双(n4 -甲基硫代氨基脲)(Cu- atsm)是一种正电子发射Cu标记的PET显像剂,在缺氧条件下被还原并困在细胞内。我们研究了几种不同组织来源的小鼠肿瘤细胞移植形成的小鼠肿瘤块中Cu-ATSM高^<64>摄取区的特征。Cu-ATSM高富集区为低血管区,由处于细胞周期停滞的肿瘤细胞组成,并伴有少量凋亡细胞。相反,FDG高积累的区域血管化良好,由活跃增殖细胞、高缺氧细胞和坏死死亡细胞组成。与血管丰富且细胞增殖的高FDG区域相比,高Cu-ATSM积累区域由于缺氧和缺乏血管,似乎对放疗和化疗具有抗性。Cu-ATSM可用于治疗计划。令人感兴趣的是,肿瘤肿块中含有大量具有如此独特特征的区域。Cu-ATSM可以描述缺氧和细胞周期阻滞区域,可能为癌症治疗提供有价值的信息。在临床小型回旋加速器生产Cu-64和制备Cu-ATSM方面,我们成功实现了从轰炸后靶盘纯化Cu-64到制备Cu-64甘氨酸溶液的自动化过程,建立了Cu-64 Cu-ATSM的安全、可重复性供应。通过对肿瘤细胞代谢特性的研究,我们发现Acss2介导的醋酸盐代谢在肿瘤细胞中高于正常细胞,并且在缺氧条件下代谢增加。这些发现提示了一种可能性,即^<11 bb0 C-acetate PET显示了肿瘤细胞中乙酸代谢的缺氧上调。
英文摘要
Noninvasive imaging of tumor hypoxia would be a great help to predict therapy outcome and make treatment planning. Cu-diacetyl-bis (N4-methylthiosemicarbazone) (Cu-ATSM) labeled with positron-emitting Cu is a PET imaging agent which is reduced and trapped in cells under hypoxia. We examined the characteristics of high ^<64>Cu-ATSM uptake regions in mouse tumor mass formed by transplantation of several mouse tumor cells of different tissue origin. The high Cu-ATSM accumulation regions were hypovascular and consisted of tumor cells arrested in the cell cycle, with a few apoptotic cells. In contrast, the regions with high FDG accumulation were well vascularized and consisted of actively proliferating cells as well as highly hypoxic cells and dying cells from necrosis. The region of high Cu-ATSM accumulation seemed to be resistant to radiation and chemotherapy because of hypoxia and lack of vessels compared to high FDG regions where vessels are abundant and cells are proliferating. Cu-ATSM could be useful for therapy planning. It was intriguing that tumor mass contains regions with such unique characteristics in substantial volume. ^<64>Cu-ATSM, which can delineate hypoxic and cell cycle-arrested regions, may provide valuable information for cancer treatment.As for the production of Cu-64 by clinical small cyclotron and preparation of Cu-ATSM, we have successfully automated the process from the purification of Cu-64 from the target disc after bomberment to preparation of Cu-64 glycine solution, which established safe and reproducible supply of Cu-64 Cu-ATSM.Studying the characteristics of tumor cell metabolism, we found that acetate metabolism mediated by Acss2 in tumor cells was higher than in normal cells, and the metabolism was increased under hypoxia. These findings suggest a possibility that ^<11>C-acetate PET is visualizing hypoxic up-regulation of acetate metabolism in tumor cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
腫瘍内Cu-ATSM高集積部位の細胞増殖能
瘤内 Cu-ATSM 积累高的区域的细胞增殖能力
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[古川 高子, 佐賀 恒夫, 藤林 靖久]
通讯作者:
藤林 靖久
Cu-ATSM Accumulation Level and Proliferation Capacity of the Tumor Cells in Solid Tumor mass
实体瘤块中Cu-ATSM的积累水平和肿瘤细胞的增殖能力
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[Furukawa T, Oh M, Tanaka T, Saga T, Fujibayashi Y]
通讯作者:
Fujibayashi Y
^<64>Cu-ATSMと18FDGの腫瘍内分布の検討
^<64> Cu-ATSM 和 18FDG 瘤内分布检查
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[呉 明美, 古川 高子, 藤林 靖久, 米倉 義晴]
通讯作者:
米倉 義晴
Proliferation Potential of the cells in The region of high Cu-ATSM accumulation within tumor mass
肿瘤块内 Cu-ATSM 高积累区域中细胞的增殖潜力
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[Furukawa T, Saga T, Fujibayashi Y]
通讯作者:
Fujibayashi Y
Double tracer autoradiography with FDG/Cu-ATSM and immunohistochemical interpretation in 4 different mouse implanted tumor models
在 4 种不同的小鼠植入肿瘤模型中使用 FDG/Cu-ATSM 双示踪剂放射自显影和免疫组织化学解释
DOI:
--
发表时间:
2005
期刊:
影响因子:
--
作者:
[Tanaka, T., Furukawa, T., Kasamatsu, S., Takamatsu, S., Sunaga, H., Fujieda, H., Naiki, H., Yonekura, Y., Fujibayashi, Y]
通讯作者:
Y
共 10 条
Basic studies for the development of a PET cancer imaging agent utilizing physical and biological properties of Zn-63
-
批准号:20591488
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.58万
-
财政年份:2008
-
负责人:FURUKAWA Takako
-
依托单位:
Constitution and Function of human SWI/SNF Complex : Implication in supression of carcionogenesis
-
批准号:14580657
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:2002
-
负责人:FURUKAWA Takako
-
依托单位:
国内基金
海外基金
登录
查看更多内容
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
-
批准号:QN25H220002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:顾媛
-
依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王锐智
-
依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造
血干细胞生成中的作用及机制研究
-
批准号:TGY24H080011
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李鸿鹄
-
依托单位:
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
-
批准号:82305053
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王丽明
-
依托单位:
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
-
批准号:82371799
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:杨程德
-
依托单位:
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
-
批准号:82371145
-
项目类别:面上项目
-
资助金额:46.00万元
-
批准年份:2023
-
负责人:陶永
-
依托单位:
IL-4协同精氨酸优化种植初期巨噬细胞胞葬作用和成骨微环境的作用及机制研究
-
批准号:82370923
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张文杰
-
依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
-
批准号:82370976
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑凌艳
-
依托单位: